Here, we show that FGF1 can stimulate ER phosphorylation and activation in some breast cancer cells and we suggest that one important effect is metabolic reprogramming of aggressive cancer cells toward a glycolytic phenotype. Here, FGF1 is linked to breast carcinoma.